Albert I Ko Selected Research

Albert I Ko Research Topics

Disease

53	COVID-19 06/2024 - 01/2020
35	Infections 12/2023 - 08/2003
29	Leptospirosis 01/2022 - 08/2003
8	Disease Progression 01/2023 - 01/2013
7	Meningitis 01/2020 - 05/2007
3	Inflammation (Inflammations) 01/2022 - 05/2020
2	Malaria 12/2022 - 05/2021
2	Fever (Fevers) 10/2022 - 01/2020
2	Reinfection 01/2022 - 03/2021
2	Pre-Eclampsia (Preeclampsia) 01/2021 - 01/2021
2	Pregnancy Complications 01/2021 - 01/2021
2	Tuberculosis (Tuberculoses) 01/2018 - 03/2013
2	Bacterial Meningitis 01/2013 - 11/2011
2	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 11/2011 - 01/2002
1	Bites and Stings (Sting) 04/2024
1	Dysbiosis 11/2022
1	Bacteremia 11/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Infertility (Sterility) 01/2022
1	Congenital Abnormalities (Deformity) 01/2022
1	Acute malaria 05/2021
1	Asymptomatic Infections 01/2021
1	Albuminuria 01/2021
1	Zika Virus Infection 01/2021

Drug/Important Bio-Agent (IBA)

19	AntibodiesIBA 12/2023 - 05/2007
17	VaccinesIBA 06/2024 - 08/2007
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
12	CytokinesIBA 01/2023 - 01/2013
9	AntigensIBA 03/2022 - 08/2003
8	Immunoglobulin G (IgG)IBA 12/2023 - 01/2013
6	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2020
5	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 11/2011
5	Antiviral Agents (Antivirals)IBA 03/2022 - 01/2020
5	sinovac COVID-19 vaccineIBA 01/2022 - 01/2021
5	Neutralizing AntibodiesIBA 01/2022 - 01/2021
4	COVID-19 VaccinesIBA 06/2024 - 01/2022
4	Messenger RNA (mRNA)IBA 06/2024 - 01/2020
4	EpitopesIBA 12/2022 - 10/2014
4	ChemokinesIBA 02/2021 - 11/2016
4	Immunoglobulin M (IgM)IBA 01/2018 - 05/2007
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2023
3	SARS-CoV-2 spike proteinIBA 12/2022 - 01/2021
3	Complement System Proteins (Complement)IBA 03/2022 - 01/2021
3	Membrane Proteins (Integral Membrane Proteins)IBA 02/2021 - 03/2009
3	EicosanoidsIBA 01/2021 - 07/2020
3	LipidsIBA 01/2021 - 07/2020
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 05/2007
3	CreatinineIBA 01/2021 - 03/2010
3	Penicillins (Penicillin)FDA Link 07/2015 - 01/2002
3	Conjugate VaccinesIBA 02/2011 - 05/2007
2	CarbohydratesIBA 12/2022 - 05/2021
2	remdesivirIBA 01/2022 - 12/2021
2	AutoantibodiesIBA 02/2021 - 01/2021
2	InterferonsIBA 01/2021 - 01/2021
2	Viral RNAIBA 01/2021 - 10/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2013
2	Kynurenic Acid (Kynurenate)IBA 01/2021 - 09/2020
2	EnzymesIBA 01/2021 - 09/2007
2	WastewaterIBA 01/2021 - 10/2020
2	DNA (Deoxyribonucleic Acid)IBA 03/2018 - 09/2017
2	Tuberculin (PPD)IBA 01/2018 - 01/2015
2	CathelicidinsIBA 09/2017 - 11/2016
2	ProteomeIBA 01/2017 - 01/2013
2	Subunit VaccinesIBA 01/2017 - 08/2007
2	Peptides (Polypeptides)IBA 11/2016 - 10/2014
2	PotassiumIBA 04/2014 - 03/2010
2	AntioxidantsIBA 04/2014 - 12/2007
1	mRNA VaccinesIBA 06/2024
1	Salivary Proteins and PeptidesIBA 04/2024
1	AllantoinIBA 01/2023
1	Tryptophan (L-Tryptophan)FDA Link 01/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	Glucuronic Acid (Glucuronate)IBA 01/2023
1	PlasminogenIBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 12/2022
1	Inactivated VaccinesIBA 10/2022
1	2-(2,4-dimethylphenyl)indan-1,3-dioneIBA 03/2022
1	Ad26COVS1IBA 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	ChAdOx1 nCoV-19IBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	renalaseIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	syncytinIBA 01/2022
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	AlbuminsIBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	AerosolsIBA 12/2020
1	Glutamic Acid (Glutamate)FDA Link 09/2020

Therapy/Procedure

8	Therapeutics 01/2022 - 12/2007
1	Patient Transfer (Patient Dumping) 01/2023
1	Ambulatory Care (Outpatient Care) 10/2022
1	Cardiopulmonary Resuscitation (CPR) 01/2022
1	Organ Transplantation 03/2021